Intellectual Property

Allergen Sequences and cDNA

 

Indoor Biotechnologies has a worldwide exclusive license agreement with Allergopharma Joachim Ganzer KG (Hamburg, Germany) for production of recombinant allergen proteins and cDNA for research use. Indoor Biotechnologies also has worldwide, exclusive rights to market cockroach allergen sequences, covered by US Patent 5,869,288, from the University of Virginia Patent Foundation. Indoor Biotechnologies Inc. has a license with Research Corporation Technologies (Tucson, AZ) for production of recombinant allergens in Pichia pastoris expression systems.

There are no products to list in this category.
    54.225.47.94
© 2017 INDOOR Biotechnologies, Inc.      Find us on: